BRIEF-EMA's CHMP Approves New Manufacturing Site For Active Substance Of COVID-19 Vaccine Nuvaxovid

European Medicines Agency:

* EMA: EMA'S CHMP APPROVED A NEW MANUFACTURING SITE FOR THE ACTIVE SUBSTANCE OF COVID-19 VACCINE NUVAXOVID: 05/07/2022 Further company coverage:

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)